BioLife Solutions, Inc. is a life sciences company. The Company develops, manufactures, and markets bioproduction tools and services which are designed to improve quality and de-risk biologic manufacturing, storage, distribution, and transportation in the cell and gene therapy (CGT) industry and broader biopharma markets. Its products are used in basic and applied research and commercial manufacturing of biologic-based therapies. Its bioproduction tools and services are comprised of three lines: Cell processing, Freezers and thaw systems and Biostorage services. Its proprietary biopreservation media products, HypoThermosol FRS and CryoStor Freeze Media, are formulated to mitigate preservation-induced, delayed-onset cell damage and death. Its ThawSTAR line includes thawing products that control the temperature and timing of the thawing process of biologic material. It operates five storage facilities in the United States and one facility in the Netherlands.